Fierce Pharma Marketing Tees up Trends for 2021—and Big News, They're Not All COVID-19-Related

In this Fierce Pharma article, Leigh Householder at Syneos Health, shares: “It really is a pivot point. Pharma organizations [should] stand forward as the innovators they’ve always been. Creating change for people, creating longer lives and opportunities for better health.”

J&J's pharma group quietly undergoes global overhaul

DOJ says it's premature for Supreme Court to hear case challenging legality of ACA

Editor's corner: The top 10 Fierce Pharma Marketing stories of 2021 recapped

Survey XII: Digital New Normal 2025 – After the Outbreak, Imagining the Internet

The Evolving State of Continuous Processing in Pharmaceutical API Manufacturing: A Survey of Pharmaceutical Companies and Contract Manufacturing Organizations

Trust in biopharma during COVID-19

Industry Voices—2020 should be the year we invest in mental health as health

Prescription Weight Loss Drugs for Obesity Work—If Your Doctor Lets You Get Them - Bloomberg

CMS looks to permanently expand telehealth services

If I'm Out of Insulin, I'm Going to Die”: United States' Lack of Regulation Fuels Crisis of Unaffordable Insulin

Pharma prices continue to rise in the US – or do they? - Pharmaceutical Technology

8 Pharma Trends for 2022: Towards a more holistic understanding of value

Watch Bloomberg Markets: The Close 12/4/23 - Bloomberg

COVID-19, C&EN - American Chemical Society COVID-19

Webinars Archives - Center for Information & Study on Clinical Research Participation